Skip to main content
. 2022 Nov 24;14(12):2594. doi: 10.3390/pharmaceutics14122594

Figure 4.

Figure 4

Doxorubicin (DOX) release profiles of DOX-loaded MCP50 (mPEG-CC-pONBMA) and MSP50 (mPEG-SS-pONBMA) performed in PBST (PBS+0.2% Tween20) at pH 7.4 and 37 °C under four conditions: without any treatment (control), in the presence of 5 mM glutathione (GSH), under UV irradiation for 7 min, in the presence of 2.5 mM GSH and under UV irradiation for 3.5 min.